Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Nov;73(5):1258-1262.
doi: 10.1016/j.jhep.2020.06.034. Epub 2020 Jul 6.

Inflammasome activation and pyroptosis in lymphopenic liver patients with COVID-19

Alexander Kroemer  1 , Khalid Khan  2 , Matthew Plassmeyer  3 , Oral Alpan  3 , M A Haseeb  4 , Raavi Gupta  4 , Thomas M Fishbein  2
Affiliations
Comment

Inflammasome activation and pyroptosis in lymphopenic liver patients with COVID-19

Alexander Kroemer et al. J Hepatol. 2020 Nov.
No abstract available

Keywords: COVID-19; Caspase-1; Chronic liver disease; Comorbidities; Inflammasome; Liver cirrhosis; Liver transplantation; Lymphopenia; Pyroptosis; T cells.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.

Comment on

References

    1. Ji D., Qin E., Xu J., Zhang D., Cheng G., Wang Y. Non-alcoholic fatty liver diseases in patients with COVID-19: a retrospective study. J Hepatol. 2020;73:451–453. - PMC - PubMed
    1. Moon A.M., Webb G.J., Aloman C., Armstrong M.J., Cargill T., Dhanasekaran R. High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: preliminary results from an international registry. J Hepatol. 2020;73(3):705–708. - PMC - PubMed
    1. Webb G.J., Moon A.M., Barnes E., Barritt A.S., Marjot T. Determining risk factors for mortality in liver transplant patients with COVID-19. Lancet Gastroenterol Hepatol. 2020;5:643–644. - PMC - PubMed
    1. Richardson S., Hirsch J.S., Narasimhan M., Crawford J.M., McGinn T., Davidson K.W. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with covid-19 in the New York City area. JAMA. 2020;323:2052–2059. - PMC - PubMed
    1. Onder G., Rezza G., Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020 - PubMed